Collaborative project: Development and implementation of a COVID-19 scFv-TRAP portfolio for diagnostic and therapeutic applications; Subproject: Development of an antibody fragment-polymer conjugate as a multivalent therapeutic agent against viruses
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:1 publications
Grant number: 01DP21012
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$173,542.11Funder
Federal Ministry of Research, Technology and Space (BMFTR)Principal Investigator
N/A
Research Location
GermanyLead Research Institution
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener VereinResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
N/A
1 Publication linked via Europe PMC
Last Updated:6 days ago
View all publications at Europe PMC